Date
Oct 21, 2026 · 8:00–9:00 AM
Location
Online
Price
See organizer
About this event
Life sciences organizations across Canada are under rising pressure to modernize their infrastructure and prove that sensitive R&D, clinical, manufacturing, and patient data stays sovereign. Yet with standard public XaaS platforms (AWS, Azure, etc.), “Canada regions” don’t automatically guarantee sovereignty: foreign ownership can still expose data to extraterritorial access (notably under the U.S. CLOUD Act), and complex sub-processor chains can quietly move telemetry, support access, or backup
